PATENT CLAIM ANALYSIS

Application Number: 15968116
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["435", "188000"]

Abstract:
Described herein are heme-binding compositions and methods relating to their use, e.g. methods of treatment of, for example, sepsis and rhabdomyolysis.

Claim (Index 38):
The composition of  claim 35 , wherein the hemopexin domain is a polypeptide comprising the sequence of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.3
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14892252', '14961144', '14174167', '13822215', '13639381']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5624171438722603
- 35 USC 102 Novelty (BERT): 0.5409931242325275
- Combined Prediction Score: 0.560274741908287
- Mean Citation Score: 237.732734
- Max Citation Score: 403.19165
- Similarity Product: 292.7170702256202

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test